2R Invest ApS: Financial statements 2025
CVR: 39715074
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
2R Invest ApS (CVR 39715074) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 14,212,649 and a net result of DKK 14,440,667. Equity in the 2025 report amounted to DKK 16,913,180. The solvency ratio was 93.2%.
- Gross Profit
- DKK 14,212,649
- Profit/Loss
- DKK 14,440,667
- Equity
- DKK 16,913,180
- Total Assets
- DKK 18,139,680
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 14.2M | 14.4M | 16.9M | 0 |
| 2023 | - | -1.7M | -19.9M | 560K | - |
| 2022 | - | -1.4M | -4M | 20.4M | - |
| 2021 | - | -1.2M | -2.9M | 24.4M | 1 |
Official annual report
How creditworthy is 2R Invest ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 17, 2025, PIASTER REVISORERNE, GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of 2R Invest ApS.
About 2R Invest ApS
2R Invest ApS is a Danish company of the type Anpartsselskab based in Ølstykke, founded in 2018. The company is registered under the industry Investering for egen regning. The company was previously named 2R Vital ApS and Mermaid Medical Vascular ApS. The management consists of Jan Rasmussen. The company is owned by Direct Invest ApS. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK -59,515 and a net result of DKK -90,435 compared with DKK 14,440,667 the year before. Equity in the 2026 report amounted to DKK 16,822,746.